D-0392-2021 Class III Terminated

Recalled by Ascend Laboratories LLC — Parsippany, NJ

FDA drug recall D-0392-2021 was initiated by Ascend Laboratories LLC on Apr 29, 2021 and is designated Class III. Reason for recall: Presence of Foreign Tablet/Capsule The recall status is terminated (terminated Feb 17, 2023). Affected quantity: 34296 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 2, 2021
Initiation Date
Apr 29, 2021
Termination Date
Feb 17, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
34296 bottles

Product description

Olmesartan Medoxomil Tablets, USP, 20 mg, Rx Only, 30 Tablets, Manufactured by Alkem Laboratories Ltd, Mumbai, 400 013. INDIA, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054, NDC 67877-446-30.

Reason for recall

Presence of Foreign Tablet/Capsule

Distribution pattern

Nationwide

Code information

Batch No. 20122548, Exp Date: Aug. 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0392-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0392-2021. Report a data issue: hello@regdatalab.com.